
### [NCIT:C9470](http://purl.obolibrary.org/obo/NCIT_C9470)
**Label:** Systemic Anaplastic Large Cell Lymphoma

**Subclasses:** [NCIT:C27366](http://purl.obolibrary.org/obo/NCIT_C27366) (Adult Systemic Anaplastic Large Cell Lymphoma), [NCIT:C9471](http://purl.obolibrary.org/obo/NCIT_C9471) (Childhood Systemic Anaplastic Large Cell Lymphoma), [NCIT:C37196](http://purl.obolibrary.org/obo/NCIT_C37196) (Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C37195](http://purl.obolibrary.org/obo/NCIT_C37195) (Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive), 

**Class expressions from DL-Learner:**

- [NCIT:C39687](http://purl.obolibrary.org/obo/NCIT_C39687) (Activated Mature Cytotoxic T-Lymphocyte) 60.00%
- [NCIT:C38324](http://purl.obolibrary.org/obo/NCIT_C38324) (Mature Cytotoxic T-Lymphocyte) 60.00%
- Thing 51.82%
- [CL:0000911](http://purl.obolibrary.org/obo/CL_0000911) (effector T cell) 45.36%
- [CL:0000910](http://purl.obolibrary.org/obo/CL_0000910) (cytotoxic T cell) 45.36%
- [CL:0000910](http://purl.obolibrary.org/obo/CL_0000910) (cytotoxic T cell) and (not ([NCIT:C40124](http://purl.obolibrary.org/obo/NCIT_C40124) (Fallopian Tube Carcinosarcoma))) 45.36%
- [CL:0000910](http://purl.obolibrary.org/obo/CL_0000910) (cytotoxic T cell) and (not ([NCIT:C40122](http://purl.obolibrary.org/obo/NCIT_C40122) (Pelvic Pain))) 45.36%
- [CL:0000910](http://purl.obolibrary.org/obo/CL_0000910) (cytotoxic T cell) and (not ([NCIT:C40116](http://purl.obolibrary.org/obo/NCIT_C40116) (Fallopian Tube Metaplastic Papillary Tumor))) 45.36%
- [CL:0000910](http://purl.obolibrary.org/obo/CL_0000910) (cytotoxic T cell) and (not ([NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma))) 45.36%
- [CL:0000910](http://purl.obolibrary.org/obo/CL_0000910) (cytotoxic T cell) and (not ([NCIT:C40112](http://purl.obolibrary.org/obo/NCIT_C40112) (Fallopian Tube Papilloma))) 45.36%
- [CL:0000910](http://purl.obolibrary.org/obo/CL_0000910) (cytotoxic T cell) and (not ([NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor))) 45.36%
- [CL:0000910](http://purl.obolibrary.org/obo/CL_0000910) (cytotoxic T cell) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 45.36%
- [CL:0000910](http://purl.obolibrary.org/obo/CL_0000910) (cytotoxic T cell) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 45.36%
- [CL:0000910](http://purl.obolibrary.org/obo/CL_0000910) (cytotoxic T cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 45.36%
- [CL:0000910](http://purl.obolibrary.org/obo/CL_0000910) (cytotoxic T cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 45.36%


